Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Junmei Hou

FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer

Multidisciplinary

English

Related publications

Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer

English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer

Cancer Research

English

Comparing Human Pancreatic Cell Secretomes by in Vitro Aptamer Selection Identifies Cyclophilin B as a Candidate Pancreatic Cancer Biomarker

Journal of Clinical Investigation

English

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

Frontiers in Pharmacology

English

Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Cancer Management and Research

English

Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway

International Journal of Biological Sciences

Applied Microbiology

Developmental Biology

Molecular Biology

English

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

English

A Phase I Study of Imexon Plus Gemcitabine as First-Line Therapy for Advanced Pancreatic Cancer

Cancer Chemotherapy and Pharmacology

Cancer Research

English

P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells

Clinical Cancer Research

Cancer Research

English